Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Psychiatry

Neuro/Psych Pharmacol

Effect of switching to brexpiprazole on plasma homovanillic acid levels and antipsychotic-related side effects in patients with schizophrenia or schizoaffective disorder

Neuropsychiatric Disease and Treatment | Apr 19, 2021 Neuro/Psych Pharmacol

Randomized double‐blind trial of intramuscular droperidol, ziprasidone, and lorazepam for acute undifferentiated agitation in the emergency department

Academic Emergency Medicine | Apr 16, 2021 Neuro/Psych Pharmacol

Methadone and buprenorphine discontinuation among postpartum women with opioid use disorder

American Journal of Obstetrics and Gynecology | Apr 15, 2021 Neuro/Psych Pharmacol

Acute cognitive effects of single-dose intravenous ketamine in major depressive and posttraumatic stress disorder

Translational Psychiatry | Apr 12, 2021 Neuro/Psych Pharmacol

Safety and tolerability of cariprazine in patients with schizophrenia: A pooled analysis of eight phase II/III studies

Neuropsychiatric Disease and Treatment | Apr 11, 2021 Neuro/Psych Pharmacol

Cost-effectiveness of treatments for opioid use disorder

JAMA | Apr 03, 2021 Neuro/Psych Pharmacol

Modelling the intervention effect of opioid agonist treatment on multiple mortality outcomes in people who inject drugs: A three-setting analysis

The Lancet Psychiatry | Mar 31, 2021 Neuro/Psych Pharmacol

Combining behavioral harm-reduction treatment and extended-release naltrexone for people experiencing homelessness and alcohol use disorder in the USA: A randomised clinical trial

The Lancet Psychiatry | Mar 30, 2021 Neuro/Psych Pharmacol

Cytisine vs varenicline for smoking cessation in New Zealand indigenous Māori: A randomized controlled trial

Addiction | Mar 29, 2021 Neuro/Psych Pharmacol

The use of liraglutide 3.0 mg daily in the management of overweight and obesity in people with schizophrenia, schizoaffective disorder and first episode psychosis: Results of a pilot randomised double‐blind placebo‐controlled trial

Diabetes, Obesity and Metabolism | Feb 09, 2021 Neuro/Psych Pharmacol

« Prev 1 … 6 7 8 9 10 … 39 Next »

Effect of switching to brexpiprazole on plasma homovanillic acid levels and antipsychotic-related side effects in patients with schizophrenia or schizoaffective disorder

Randomized double‐blind trial of intramuscular droperidol, ziprasidone, and lorazepam for acute undifferentiated agitation in the emergency department

Methadone and buprenorphine discontinuation among postpartum women with opioid use disorder

Acute cognitive effects of single-dose intravenous ketamine in major depressive and posttraumatic stress disorder

Safety and tolerability of cariprazine in patients with schizophrenia: A pooled analysis of eight phase II/III studies

Cost-effectiveness of treatments for opioid use disorder

Modelling the intervention effect of opioid agonist treatment on multiple mortality outcomes in people who inject drugs: A three-setting analysis

Combining behavioral harm-reduction treatment and extended-release naltrexone for people experiencing homelessness and alcohol use disorder in the USA: A randomised clinical trial

Cytisine vs varenicline for smoking cessation in New Zealand indigenous Māori: A randomized controlled trial

The use of liraglutide 3.0 mg daily in the management of overweight and obesity in people with schizophrenia, schizoaffective disorder and first episode psychosis: Results of a pilot randomised double‐blind placebo‐controlled trial

Alternative Therapies and Infection Management

'Weekend Warrior' Trend: Health Perks for Busy Physicians

Pulmonary Embolism: MCQs Challenge

Pelvic Floor Disorders: Causes, Diagnosis & Treatment

Top Foods to Combat Winter Illness

Effect of switching to brexpiprazole on plasma homovanillic acid levels and antipsychotic-related side effects in patients with schizophrenia or schizoaffective disorder

Randomized double‐blind trial of intramuscular droperidol, ziprasidone, and lorazepam for acute undifferentiated agitation in the emergency department

Methadone and buprenorphine discontinuation among postpartum women with opioid use disorder

Acute cognitive effects of single-dose intravenous ketamine in major depressive and posttraumatic stress disorder

Safety and tolerability of cariprazine in patients with schizophrenia: A pooled analysis of eight phase II/III studies

Cost-effectiveness of treatments for opioid use disorder

Modelling the intervention effect of opioid agonist treatment on multiple mortality outcomes in people who inject drugs: A three-setting analysis

Combining behavioral harm-reduction treatment and extended-release naltrexone for people experiencing homelessness and alcohol use disorder in the USA: A randomised clinical trial

Cytisine vs varenicline for smoking cessation in New Zealand indigenous Māori: A randomized controlled trial

The use of liraglutide 3.0 mg daily in the management of overweight and obesity in people with schizophrenia, schizoaffective disorder and first episode psychosis: Results of a pilot randomised double‐blind placebo‐controlled trial

Alternative Therapies and Infection Management

'Weekend Warrior' Trend: Health Perks for Busy Physicians

Pulmonary Embolism: MCQs Challenge

Pelvic Floor Disorders: Causes, Diagnosis & Treatment

Top Foods to Combat Winter Illness

Select Specialty

Select Topic